Cargando…
VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
Current therapeutic anti-angiogenic biologics used for the treatment of pathological ocular angiogenesis such as in diabetic retinopathy and wet macular degeneration often lead to detrimental side effects due to their interference with normal blood vessel physiology. In this issue of EMBO Molecular...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BlackWell Publishing Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023881/ https://www.ncbi.nlm.nih.gov/pubmed/24803395 http://dx.doi.org/10.1002/emmm.201404026 |